EGF anticorps
Aperçu rapide pour EGF anticorps (ABIN5688983)
Antigène
Voir toutes EGF AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Purification
- Anti-hEGF specific antibody was purified by affinity chromatography employing immobilized hEGF matrix.
-
Immunogène
- Produced from sera of rabbits pre-immunized with highly pure (>98%) recombinant hEGF.
-
-
-
-
Indications d'application
-
Neutralization:
To yield one-half maximal inhibition [ND50] of the biological activity of hEGF (2.0 ng/mL), a concentration of 0.25 0.35 μ,g/mL of this antibody is required.
ELISA:
To detect hEGF by direct ELISA (using 100us antibody can be used at a concentration of 0.1 - 0.2 μ,g/mL. Used in conjunction with compatible secondary reagents the detection limit for recombinant hEGF is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions.
Sandwich: To detect hEGF by sandwich ELISA (using 100 μ,L/well antibody solution) a concentration of 0.5 - 2.0 μ,g/mL of this antibody is required. This antigen affinity purified antibody, in conjunction with our Biotinylated Anti-Human EGF (XP-5119Bt) as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant hEGF.
Western Blot:
To detect hEGF by Western Blot analysis this antibody can be used at a concentration of 0.1 - 0.2 μ,g/mL. Used in conjunction with compatible secondary reagents the detection limit for recombinant hEGF is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions. -
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Stock
- -20 °C
-
Stockage commentaire
- EGF antibody is stable for at least 2 years from date of receipt at -20°C. The reconstituted antibody is stable for at least two weeks at 2-8°C. Frozen aliquots are stable for at least 6 months when stored at -20°C. Avoid repeated freeze-thaw cycles.
-
-
- EGF (Epidermal Growth Factor (EGF))
-
Autre désignation
- EGF
-
Poids moléculaire
- 6.2 kDa
-
ID gène
- 1950
-
UniProt
- P01133
-
Pathways
- Signalisation NF-kappaB, Signalisation RTK, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Regulation of Carbohydrate Metabolic Process, Hepatitis C, Protein targeting to Nucleus, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, EGFR Downregulation
Antigène
-